Physiomics Plc

Stocks

Market Closed - London S.E. 11:35:25 2026-10-23 EDT			5-day change	1st Jan Change
0.4750 ^GBX	0.00%		0.00%	+66.67%

10-20	Optima Health sales jump; Shearwater contract win	AN
10-20	Physiomics Secures Model-informed Drug Development Contract	MT

Published on 04/10/2026 at 09:20 am EDT - Modified on 04/10/2026 at 09:35 am EDT

S&P Capital IQ

Presentation Operator Message
Operator (Operator)

Good afternoon, and welcome to the Physiomics Plc investor presentation. [Operator Instructions] Before we begin, I'd like to submit the following

This article is reserved for our subscribers.

Subcribe
to read the article

Unlimited browsing across the entire site

Access to all news and data

US, Europe, and Asia portfolios

Ad-free reading

Pro Tools : expert screeners, historical financials, PDF reports, investment themes, and earnings transcripts

10-20	Optima Health sales jump; Shearwater contract win	AN
10-20	Physiomics Secures Model-informed Drug Development Contract	MT
10-20	Physiomics plc Announces Contract Award Valued At £102,000	CI
10-14	Xaar hires Bodycote's Daniel Dayan as new chair	AN
10-14	Physiomics Wins Model-informed Drug Development Modeling Contract	MT
10-13	EARNINGS AND TRADING: Physiomics loss widens despite revenue increase	AN
10-13	Physiomics Plc Reports Earnings Results for the Full Year Ended June 30, 2026	CI
10-13	Earnings Flash (PYC.L) Physiomics PLC Reports FY26 Revenue GBP941,222	MT
09-23	WINNERS & LOSERS: BSF Enterprise gets US patent; Ingenta profit down	AN
09-10	EARNINGS AND TRADING: Physiomics celebrates new contract wins	AN
09-10	Physiomics Wins New Contracts	MT
09-10	Physiomics plc Secures New Contract Wins with Combined Value of More Than £205,000	CI
07-13	WINNERS & LOSERS: Ixico lower order book; Pennant sees revenue jump	AN
07-08	Gym Group revenue rises; Central Asia output up	AN
07-08	Physiomics Secures New, Extended Contracts	MT

Duration

Period

Sector